NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/14/2022
Back to search
Official data from USPTO
CILOXAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
08/14/2022
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
10/12/1990
Registration date
09/15/1992
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2022
Last transaction
08/13/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/24/1991
First use in commerce
01/24/1991
Drawing code
5
Owner type
03
Owner location
BASEL, CH
Examiner
BLUE, RACHEL
Law office
G50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
NOVARTIS AG
ALCON RESEARCH, LTD.
ALCON MANUFACTURING, LTD.
ALCON MANUFACTURING, LTD
Alcon Laboratories, Inc.
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
ophthalmic pharmaceutical preparation for the treatment of infection and inflammation
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
08/13/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/13/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/13/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
02/23/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/15/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/24/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/24/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/22/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/27/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/27/2016
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/23/2012
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
01/23/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/23/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
11/17/2011
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/02/2008
CFIT
CASE FILE IN TICRS
03/03/2008
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/15/2007
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/11/2002
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/11/2002
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
10/17/2001
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/10/1997
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
09/19/1997
R.PR
REGISTERED-PRINCIPAL REGISTER
09/15/1992
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/30/1992
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/08/1992
IUAF
USE AMENDMENT FILED
05/21/1992
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/24/1992
PUBO
PUBLISHED FOR OPPOSITION
05/14/1991
NPUB
NOTICE OF PUBLICATION
04/12/1991
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/1991
DOCK
ASSIGNED TO EXAMINER
02/06/1991
Continuous trademark protection
Get notified about every new filing that threatens CILOXAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.